University of Texas at Dallas
Richardson, Texas, 75080, United States
Location status: Recruiting
Location contact
McKenzie Cullinan, MS
CONTACT
Pumpki L. Su, PhD
CONTACT
Pumpki L. Su, PhD
PRINCIPAL_INVESTIGATOR
NCT Number: NCT06649916
The overall objective of this research is to determine whether parentese delivered in the video format (Aim 1) and in live interaction (Aim 2) facilitates novel word learning in autistic children and to investigate if there are factors that influence the effect of parentese on word learning (Aim 3).
Interested in participating?
Request Info18 month–59 month
All sexes
Interventional
Not applicable
Richardson, Texas, 75080, United States
Location status: Recruiting
McKenzie Cullinan, MS
CONTACT
Pumpki L. Su, PhD
CONTACT
Pumpki L. Su, PhD
PRINCIPAL_INVESTIGATOR
Caregivers frequently use parentese, also known as infant-directed speech (IDS), when speaking to young children. Compared to adult registered speech, parentese is typically characterized by greater pitch variation, longer duration, and louder volume. Parentese facilitates early language development in typically developing (TD) children. However, it remains unknown whether the facilitative effect of parentese on language learning can be generalized to clinical populations such as autistic children given that core autism features (e.g., sensory and social communication differences) may interact with how they process and learn from parentese. Most autistic children do not reach age-appropriate language ability even if they receive timely early intervention. Determining if autistic children can learn language from parentese, a common way language input is provided to young children, is a critical first step toward understanding whether language input needs to be adjusted to optimize their language development.
The overall objective of this research is to determine whether parentese facilitates novel word learning in autistic children and to investigate if the effect of parentese is conditional upon input factors (recorded parentese vs live parentese presented in social interaction) and child factors (extreme responses to auditory input, social motivation). In Aim 1, the investigators will use a video-based word learning paradigm to determine the effect of recorded parentese on novel word learning in autistic children compared to language-matched TD peers. Aim 2 focuses on the effect of live parentese on novel word learning: an experimenter will teach children two novel words, presented in live parentese or live parentese, during social interaction. Aim 3 will examine whether child factors (extreme responses to auditory input, social motivation) explain variability in word learning accuracy from recorded parentese and live parentese in the autistic group. Children's extreme responses to auditory input (including hyper- and hypo-responsiveness) and social motivation will be measured using caregiver questionnaires and will be used to predict word learning accuracy from recorded parentese (Aim 1) and live parentese (Aim 2) in the autistic group.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Novel words are introduced in parentese, a type of speech that is typically characterized by greater pitch variation, longer duration, and louder volume
Other names: Infant-Directed Speech
Novel words are introduced in standard adult register.
Other names: Adult-Directed Speech
Time frame: 300 ms after the target words are introduced
Children's eye gaze is recorded as they look at images. The proportion of time during which gaze is directed to an image of the targeted word is the dependent measure.
Contact information is provided by the study sponsor or research team.
McKenzie Cullinan, MS
CONTACT
Pumpki L Su, PhD
CONTACT
The University of Texas at Dallas
Other
Autism Word Learning and Infant Directed-Speech
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06081348
22Q11 Deletion, 22q11 Deletion Syndrome
Calgary, Alberta, Canada
View Trial DetailsNCT03866668
Autism, Autism Spectrum Disorder
Stanford, California, United States
View Trial DetailsNCT06362733
Autism, Autism Spectrum Disorder
Stanford, California, United States
View Trial DetailsNCT04899544
ASD, Autism
Stanford, California, United States
View Trial Details